Solid Tumor: Desmoplastic Small Round Cell Tumor
Alternate Names: DSRCT, polyphenotypic small round cell tumor
What is a desmoplastic small round cell tumor?
Desmoplastic small round cell tumor (DSRCT) is a type of cancer. It is usually found in the abdomen (belly), but it can also occur in other parts of the body. Tumors are formed by small, round cancer cells and are surrounded by scarlike tissue. The tumor has a specific genetic abnormality that helps confirm the diagnosis. DSRCT in the abdomen may not be found until the tumors have grown large. As a result, often the disease has spread to the liver, lymph nodes, lungs or bones by the time it is diagnosed.
How common is desmoplastic small round cell tumor?
DSRCT is extremely rare. Fewer than 200 cases have been reported, about 85 percent of them in Caucasian people.
Boys and young men are about four times as likely to have DSRCT as girls and young women. It is usually diagnosed in males between ages 10 and 30.
What are the symptoms of desmoplastic small round cell tumor?
Symptoms of desmoplastic small round cell tumor include:
- Pain or a lump in the abdomen
- Trouble having a bowel movement and/or passing gas
- Abdominal swelling
How is desmoplastic small round cell tumor treated?
Because DSRCT is so rare, no standard way to treat it has been developed. The following treatment methods have been used:
- Surgery — is used to remove as much of the cancer as possible. Often, DSRCTs have spread too far for complete removal, but surgeons try to remove at least 90 percent of them.
- Hyperthermic intraperitoneal chemotherapy (HIPEC) — may be given during the surgery to kill cancer cells that cannot be removed surgically. (The patient also avoids the side effects of standard chemotherapy.)
- HIPEC is done by circulating a heated, sterile chemo solution through the part of the abdomen where the tumors are found, for up to two hours.
- Chemotherapy (“chemo”) — uses powerful medicines to kill cancer cells or stop them from growing (dividing) and making more cancer cells.
- Chemo may be injected into the bloodstream, so that it can travel throughout the body.
- Some chemo may be given by mouth.
- Some chemo may be given by mouth.
- Radiation therapy — uses high-energy X-rays or other types of radiation to kill cancer cells or stop them from growing.
- External radiation uses machines outside the body to deliver the X-ray dose.
- Internal radiation uses needles, seeds, wires or catheters to deliver the radiation directly into or close to the cancer.
DSRCT located outside the abdomen without any spread seems to respond better to treatment than DSRCT in the abdomen or than DSRCT which has spread into other parts of the body.
What are the survival rates for desmoplastic small round cell tumor?
Because so few people have DSRCT, only a small amount of information on treatment results is available. Currently DSRCT has a 15 percent five-year survival rate. However, researchers are looking for treatments that will improve those odds.
Why choose St. Jude for your child’s desmoplastic small round cell tumor treatment?
- St. Jude has an ongoing clinical trial testing new chemotherapy drugs for newly diagnosed patients with DSRCT. This study involves DSRCT in the abdomen or pelvis when the cancer cannot be removed by surgery or has spread to other parts of the body.
- St. Jude is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
- St. Jude has created more clinical trials for cancer than any other children’s hospital in the United States.
- The nurse-to-patient ratio at St. Jude is unmatched— averaging 1:3 in hematology and oncology, and 1:1 in the Intensive Care Unit.
The St. Jude Web site is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through this site should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, you should consult your health care provider.